These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3409619)

  • 1. [Beneficial effects of plasma exchange in acute Guillain-Barré syndrome: comparison with methylprednisolone pulse therapy].
    Mori E; Yoshida T; Ohsumi Y; Tabuchi M; Yamadori A
    Rinsho Shinkeigaku; 1988 Feb; 28(2):196-203. PubMed ID: 3409619
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of acute Guillain-Barré syndrome. A national multicenter study].
    Kloss TM; Haupt WF; Philipp T; Diener HC
    Nervenarzt; 1994 Dec; 65(12):881-3. PubMed ID: 7854512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcome of severe Guillain-Barré syndrome.
    Ng KK; Howard RS; Fish DR; Hirsch NP; Wiles CM; Murray NM; Miller DH
    QJM; 1995 Apr; 88(4):243-50. PubMed ID: 7796073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T; Nakagawa H; Uchiyama F; Fukuyama J
    Rinsho Shinkeigaku; 1993 Jun; 33(6):660-2. PubMed ID: 8403689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma exchange and selective adsorption in Guillain-Barré syndrome--a comparison of therapies by clinical course and side effects.
    Rosenow F; Haupt WF; Grieb P; Jiménez-Klingberg C; Borberg H
    Transfus Sci; 1993 Jan; 14(1):13-5. PubMed ID: 10148310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of the utility of plasma-exchange in the treatment of severe Guillain-Barré syndrome.
    Garelli S
    Riv Emoter Immunoematol; 1980; 27(3-4):187-94. PubMed ID: 7339847
    [No Abstract]   [Full Text] [Related]  

  • 7. [Functional recovery in Guillain-Barre syndrome: benefits of plasma exchange].
    Cassuto-Viguier E; Sanderson F; Kullman B; Quaranta JF; Montagne N; Gueyraud A; Therre C; Duplay H
    Ann Med Interne (Paris); 1988; 139 Suppl 1():43-5. PubMed ID: 3247991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The number of plasma exchanges in Guillain-Barré syndrome: evaluation by the removal rate of immunoglobulin G].
    Tagawa Y; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1998; 38(10-11):951-4. PubMed ID: 10203982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasmapheresis-pulse therapy in chronic stage of Guillain-Barré syndrome--controlled study].
    Jyoichi T; Noda Y; Honda H; Shmojo S; Miyahara T
    Rinsho Shinkeigaku; 1987 Apr; 27(4):479-86. PubMed ID: 3304767
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous immune globulin versus plasma exchange in Guillain-Barré syndrome.
    Raphael JC; Chastang C; Chevret S; Gajdos P
    N Engl J Med; 1992 Sep; 327(11):816; author reply 817. PubMed ID: 1501669
    [No Abstract]   [Full Text] [Related]  

  • 11. Adsorption therapy with tryptophan-conjugated polyvinyl alcohol gels in 10 patients with acute Guillain-Barré syndrome.
    Jiménez C; Rosenow F; Grieb P; Haupt WF; Borberg H
    Transfus Sci; 1993 Jan; 14(1):9-11. PubMed ID: 10148309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma exchange in Guillain-Barré syndrome].
    Bisharat B; Nassar F; Dubnov B; Schonfeld S
    Minerva Med; 1984 Feb; 75(7):335-6. PubMed ID: 6700840
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of Guillain-Barré syndrome by plasma exchange. 6 cases].
    Dureux JB; Gerard A; Roche G; Leheup B; Canton P; Schooneman F; Jannot C; Streiff F
    Nouv Presse Med; 1980 Dec; 9(48):3696-7. PubMed ID: 7454587
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Guillain-Barré syndrome with intravenous methylprednisolone.
    Hughes R; Swan A
    Ann Neurol; 1995 May; 37(5):683-4. PubMed ID: 7755366
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group.
    Ann Neurol; 1994 Jun; 35(6):749-52. PubMed ID: 8210234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second response to immunoglobulin in recurrent Guillain-Barré syndrome.
    Nagappan R; Barker J
    N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasmapheresis and hormone therapy in severe forms of Guillain-Barré syndrome].
    Levchenko NI; Piradov MA; Pirogov VN
    Klin Med (Mosk); 1989 Dec; 67(12):88-91. PubMed ID: 2560799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing views of Guillain-Barré syndrome.
    Asbury AK; McKhann GM
    Ann Neurol; 1997 Mar; 41(3):287-8. PubMed ID: 9066348
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous immune globulin in the Guillain-Barré syndrome.
    van der Meché FG
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):43-7. PubMed ID: 8033434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma exchange therapy of Guillain-Barre syndrome].
    Sato T; Ishigaki Y; Matsuda K
    Nihon Naika Gakkai Zasshi; 1992 Feb; 81(2):228-31. PubMed ID: 1607782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.